(Q46145229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Radiation-guided targeting of combretastatin encapsulated immunoliposomes to mammary tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Christopher B Pattillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Berenice Venegas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Fred J Donelson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Linda C Knight

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Parkson L-G Chong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Mohammad F Kiani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

27 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1093-1100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19172383%20AND%20SRC:MED&resulttype=core&format=json

Radiation-guided drug delivery systems

20 January 2020

cites work

1 reference

12 December 2020

Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid

1 reference

12 December 2020

Combretastatin A4 phosphate: background and current clinical status

1 reference

12 December 2020

Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues.

1 reference

12 December 2020

Phosphorus assay in column chromatography

1 reference

12 December 2020

Radiation-induced up-regulation of adhesion molecules in brain microvasculature and their modulation by dexamethasone.

1 reference

12 December 2020

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

1 reference

12 December 2020

Molecular dynamics simulations of hydrophilic pores in lipid bilayers

1 reference

12 December 2020

Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin

1 reference

12 December 2020

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

1 reference

12 December 2020

A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies

1 reference

12 December 2020

A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation

1 reference

12 December 2020

Phase I trial of combretastatin a-4 phosphate with carboplatin

1 reference

12 December 2020

Vascular targeting agents as cancer therapeutics

1 reference

12 December 2020

Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate

1 reference

12 December 2020

Targeting microparticles to select tissue via radiation-induced upregulation of endothelial cell adhesion molecules.

1 reference

12 December 2020

Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements

1 reference

12 December 2020

In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment.

1 reference

12 December 2020

Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)

1 reference

12 December 2020

Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results

1 reference

12 December 2020

Targeting of the antivascular drug combretastatin to irradiated tumors results in tumor growth delay

1 reference

12 December 2020

Tumor hypoxia in cancer therapy

1 reference

12 December 2020

Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow

1 reference

12 December 2020

A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.

1 reference

12 December 2020